Used as an intermediate in pharmaceutical synthesis, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports the construction of complex drug candidates by enabling selective modifications in molecular frameworks. Commonly employed in medicinal chemistry for optimizing solubility, stability, and binding affinity of target compounds. Suitable for solid-phase and solution-phase peptide-like synthesis due to the presence of protected functional groups.